 | • レポートコード：MRC2Q12-17344 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、DNAゲノム検査のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 DNAゲノム検査のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 DNAゲノム検査の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 DNAゲノム検査のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのDNAゲノム検査の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のDNAゲノム検査の売上および2028年までの予測に焦点を当てています。 DNAゲノム検査のグローバル主要企業には、Abbott、CSL、Danaher、Eurofins Scientific、F. Hoffmann-La Roche、Illumina、Myriad Genetics、Qiagen、Thermo Fisher Scientificなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 DNAゲノム検査市場は、タイプとアプリケーションによって区分されます。世界のDNAゲノム検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 発症前予測検査、胎児＆新生児検査、薬理ゲノミクス検査、その他 【アプリケーション別セグメント】 総合病院、専門クリニック 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - DNAゲノム検査製品概要 - タイプ別市場（発症前予測検査、胎児＆新生児検査、薬理ゲノミクス検査、その他） - アプリケーション別市場（総合病院、専門クリニック） - 調査の目的 ・エグゼクティブサマリー - 世界のDNAゲノム検査販売量予測2017-2028 - 世界のDNAゲノム検査売上予測2017-2028 - DNAゲノム検査の地域別販売量 - DNAゲノム検査の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別DNAゲノム検査販売量 - 主要メーカー別DNAゲノム検査売上 - 主要メーカー別DNAゲノム検査価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（発症前予測検査、胎児＆新生児検査、薬理ゲノミクス検査、その他） - DNAゲノム検査のタイプ別販売量 - DNAゲノム検査のタイプ別売上 - DNAゲノム検査のタイプ別価格 ・アプリケーション別市場規模（総合病院、専門クリニック） - DNAゲノム検査のアプリケーション別販売量 - DNAゲノム検査のアプリケーション別売上 - DNAゲノム検査のアプリケーション別価格 ・北米市場 - 北米のDNAゲノム検査市場規模（タイプ別、アプリケーション別） - 主要国別のDNAゲノム検査市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのDNAゲノム検査市場規模（タイプ別、アプリケーション別） - 主要国別のDNAゲノム検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のDNAゲノム検査市場規模（タイプ別、アプリケーション別） - 主要国別のDNAゲノム検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のDNAゲノム検査市場規模（タイプ別、アプリケーション別） - 主要国別のDNAゲノム検査市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのDNAゲノム検査市場規模（タイプ別、アプリケーション別） - 主要国別のDNAゲノム検査市場規模（トルコ、サウジアラビア） ・企業情報 Abbott、CSL、Danaher、Eurofins Scientific、F. Hoffmann-La Roche、Illumina、Myriad Genetics、Qiagen、Thermo Fisher Scientific ・産業チェーン及び販売チャネル分析 - DNAゲノム検査の産業チェーン分析 - DNAゲノム検査の原材料 - DNAゲノム検査の生産プロセス - DNAゲノム検査の販売及びマーケティング - DNAゲノム検査の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - DNAゲノム検査の産業動向 - DNAゲノム検査のマーケットドライバー - DNAゲノム検査の課題 - DNAゲノム検査の阻害要因 ・主な調査結果 |
Genomic testing differs from genetic testing because genomic testing examines all of a person’s genes, rather than just looking at a specific gene or specific genome. Genomic testing conducts extensive testing for any genetic alterations or harmful changes in the genetic code.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for DNA Genomic Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for DNA Genomic Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for DNA Genomic Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of DNA Genomic Testing include Abbott, CSL, Danaher, Eurofins Scientific, F. Hoffmann-La Roche, Illumina, Myriad Genetics, Qiagen and Thermo Fisher Scientific, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the DNA Genomic Testing manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional DNA Genomic Testing market. Further, it explains the major drivers and regional dynamics of the global DNA Genomic Testing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott
CSL
Danaher
Eurofins Scientific
F. Hoffmann-La Roche
Illumina
Myriad Genetics
Qiagen
Thermo Fisher Scientific
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
DNA Genomic Testing Segment by Type
Predictive Presymptomatic Testing
Prenatal and Newborn Testing
Pharmacogenomic Testing
Others
DNA Genomic Testing Segment by Application
General Hospitals
Specialty Clinics
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the DNA Genomic Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for DNA Genomic Testing, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of DNA Genomic Testing, also provides the sales of main regions and countries. Highlights of the upcoming market potential for DNA Genomic Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the DNA Genomic Testing sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global DNA Genomic Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for DNA Genomic Testing sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, CSL, Danaher, Eurofins Scientific, F. Hoffmann-La Roche, Illumina, Myriad Genetics, Qiagen and Thermo Fisher Scientific, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of DNA Genomic Testing in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of DNA Genomic Testing manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA Genomic Testing sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 DNA Genomic Testing Product Introduction
1.2 Market by Type
1.2.1 Global DNA Genomic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Predictive Presymptomatic Testing
1.2.3 Prenatal and Newborn Testing
1.2.4 Pharmacogenomic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global DNA Genomic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global DNA Genomic Testing Sales Estimates and Forecasts 2017-2028
2.2 Global DNA Genomic Testing Revenue Estimates and Forecasts 2017-2028
2.3 Global DNA Genomic Testing Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global DNA Genomic Testing Sales by Region
2.4.1 Global DNA Genomic Testing Sales by Region (2017-2022)
2.4.2 Global Sales DNA Genomic Testing by Region (2023-2028)
2.5 Global DNA Genomic Testing Revenue by Region
2.5.1 Global DNA Genomic Testing Revenue by Region (2017-2022)
2.5.2 Global DNA Genomic Testing Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global DNA Genomic Testing Sales by Manufacturers
3.1.1 Global Top DNA Genomic Testing Manufacturers by Sales (2017-2022)
3.1.2 Global DNA Genomic Testing Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of DNA Genomic Testing in 2021
3.2 Global DNA Genomic Testing Revenue by Manufacturers
3.2.1 Global DNA Genomic Testing Revenue by Manufacturers (2017-2022)
3.2.2 Global DNA Genomic Testing Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by DNA Genomic Testing Revenue in 2021
3.3 Global DNA Genomic Testing Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global DNA Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global DNA Genomic Testing Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global DNA Genomic Testing Sales by Type
4.1.1 Global DNA Genomic Testing Historical Sales by Type (2017-2022)
4.1.2 Global DNA Genomic Testing Forecasted Sales by Type (2023-2028)
4.1.3 Global DNA Genomic Testing Sales Market Share by Type (2017-2028)
4.2 Global DNA Genomic Testing Revenue by Type
4.2.1 Global DNA Genomic Testing Historical Revenue by Type (2017-2022)
4.2.2 Global DNA Genomic Testing Forecasted Revenue by Type (2023-2028)
4.2.3 Global DNA Genomic Testing Revenue Market Share by Type (2017-2028)
4.3 Global DNA Genomic Testing Price by Type
4.3.1 Global DNA Genomic Testing Price by Type (2017-2022)
4.3.2 Global DNA Genomic Testing Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global DNA Genomic Testing Sales by Application
5.1.1 Global DNA Genomic Testing Historical Sales by Application (2017-2022)
5.1.2 Global DNA Genomic Testing Forecasted Sales by Application (2023-2028)
5.1.3 Global DNA Genomic Testing Sales Market Share by Application (2017-2028)
5.2 Global DNA Genomic Testing Revenue by Application
5.2.1 Global DNA Genomic Testing Historical Revenue by Application (2017-2022)
5.2.2 Global DNA Genomic Testing Forecasted Revenue by Application (2023-2028)
5.2.3 Global DNA Genomic Testing Revenue Market Share by Application (2017-2028)
5.3 Global DNA Genomic Testing Price by Application
5.3.1 Global DNA Genomic Testing Price by Application (2017-2022)
5.3.2 Global DNA Genomic Testing Price Forecast by Application (2023-2028)
6 North America
6.1 North America DNA Genomic Testing Market Size by Type
6.1.1 North America DNA Genomic Testing Sales by Type (2017-2028)
6.1.2 North America DNA Genomic Testing Revenue by Type (2017-2028)
6.2 North America DNA Genomic Testing Market Size by Application
6.2.1 North America DNA Genomic Testing Sales by Application (2017-2028)
6.2.2 North America DNA Genomic Testing Revenue by Application (2017-2028)
6.3 North America DNA Genomic Testing Market Size by Country
6.3.1 North America DNA Genomic Testing Sales by Country (2017-2028)
6.3.2 North America DNA Genomic Testing Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe DNA Genomic Testing Market Size by Type
7.1.1 Europe DNA Genomic Testing Sales by Type (2017-2028)
7.1.2 Europe DNA Genomic Testing Revenue by Type (2017-2028)
7.2 Europe DNA Genomic Testing Market Size by Application
7.2.1 Europe DNA Genomic Testing Sales by Application (2017-2028)
7.2.2 Europe DNA Genomic Testing Revenue by Application (2017-2028)
7.3 Europe DNA Genomic Testing Market Size by Country
7.3.1 Europe DNA Genomic Testing Sales by Country (2017-2028)
7.3.2 Europe DNA Genomic Testing Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific DNA Genomic Testing Market Size by Type
8.1.1 Asia Pacific DNA Genomic Testing Sales by Type (2017-2028)
8.1.2 Asia Pacific DNA Genomic Testing Revenue by Type (2017-2028)
8.2 Asia Pacific DNA Genomic Testing Market Size by Application
8.2.1 Asia Pacific DNA Genomic Testing Sales by Application (2017-2028)
8.2.2 Asia Pacific DNA Genomic Testing Revenue by Application (2017-2028)
8.3 Asia Pacific DNA Genomic Testing Market Size by Region
8.3.1 Asia Pacific DNA Genomic Testing Sales by Region (2017-2028)
8.3.2 Asia Pacific DNA Genomic Testing Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America DNA Genomic Testing Market Size by Type
9.1.1 Latin America DNA Genomic Testing Sales by Type (2017-2028)
9.1.2 Latin America DNA Genomic Testing Revenue by Type (2017-2028)
9.2 Latin America DNA Genomic Testing Market Size by Application
9.2.1 Latin America DNA Genomic Testing Sales by Application (2017-2028)
9.2.2 Latin America DNA Genomic Testing Revenue by Application (2017-2028)
9.3 Latin America DNA Genomic Testing Market Size by Country
9.3.1 Latin America DNA Genomic Testing Sales by Country (2017-2028)
9.3.2 Latin America DNA Genomic Testing Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa DNA Genomic Testing Market Size by Type
10.1.1 Middle East and Africa DNA Genomic Testing Sales by Type (2017-2028)
10.1.2 Middle East and Africa DNA Genomic Testing Revenue by Type (2017-2028)
10.2 Middle East and Africa DNA Genomic Testing Market Size by Application
10.2.1 Middle East and Africa DNA Genomic Testing Sales by Application (2017-2028)
10.2.2 Middle East and Africa DNA Genomic Testing Revenue by Application (2017-2028)
10.3 Middle East and Africa DNA Genomic Testing Market Size by Country
10.3.1 Middle East and Africa DNA Genomic Testing Sales by Country (2017-2028)
10.3.2 Middle East and Africa DNA Genomic Testing Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott DNA Genomic Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott DNA Genomic Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Overview
11.2.3 CSL DNA Genomic Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CSL DNA Genomic Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 Danaher
11.3.1 Danaher Corporation Information
11.3.2 Danaher Overview
11.3.3 Danaher DNA Genomic Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Danaher DNA Genomic Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Danaher Recent Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Corporation Information
11.4.2 Eurofins Scientific Overview
11.4.3 Eurofins Scientific DNA Genomic Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eurofins Scientific DNA Genomic Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eurofins Scientific Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Corporation Information
11.5.2 F. Hoffmann-La Roche Overview
11.5.3 F. Hoffmann-La Roche DNA Genomic Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 F. Hoffmann-La Roche DNA Genomic Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Illumina
11.6.1 Illumina Corporation Information
11.6.2 Illumina Overview
11.6.3 Illumina DNA Genomic Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Illumina DNA Genomic Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Illumina Recent Developments
11.7 Myriad Genetics
11.7.1 Myriad Genetics Corporation Information
11.7.2 Myriad Genetics Overview
11.7.3 Myriad Genetics DNA Genomic Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Myriad Genetics DNA Genomic Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Myriad Genetics Recent Developments
11.8 Qiagen
11.8.1 Qiagen Corporation Information
11.8.2 Qiagen Overview
11.8.3 Qiagen DNA Genomic Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Qiagen DNA Genomic Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Qiagen Recent Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Corporation Information
11.9.2 Thermo Fisher Scientific Overview
11.9.3 Thermo Fisher Scientific DNA Genomic Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Thermo Fisher Scientific DNA Genomic Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Thermo Fisher Scientific Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 DNA Genomic Testing Industry Chain Analysis
12.2 DNA Genomic Testing Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 DNA Genomic Testing Production Mode & Process
12.4 DNA Genomic Testing Sales and Marketing
12.4.1 DNA Genomic Testing Sales Channels
12.4.2 DNA Genomic Testing Distributors
12.5 DNA Genomic Testing Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 DNA Genomic Testing Industry Trends
13.2 DNA Genomic Testing Market Drivers
13.3 DNA Genomic Testing Market Challenges
13.4 DNA Genomic Testing Market Restraints
14 Key Findings in The Global DNA Genomic Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer